StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a report released on Friday morning. The firm issued a sell rating on the medical technology company’s stock.
BIOL has been the topic of a number of other reports. Benchmark restated a speculative buy rating and set a $0.40 price target on shares of BIOLASE in a research report on Monday, August 12th. Maxim Group cut BIOLASE from a strong-buy rating to a hold rating in a report on Friday, May 24th.
Check Out Our Latest Stock Report on BIOL
BIOLASE Stock Performance
BIOLASE (NASDAQ:BIOL – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The medical technology company reported ($0.08) EPS for the quarter. The firm had revenue of $11.56 million during the quarter. BIOLASE had a negative net margin of 43.56% and a negative return on equity of 1,782.73%.
Institutional Trading of BIOLASE
A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC raised its position in BIOLASE, Inc. (NASDAQ:BIOL – Free Report) by 1,068.0% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the period. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 as of its most recent filing with the SEC. Institutional investors own 8.79% of the company’s stock.
BIOLASE Company Profile
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.
Featured Articles
- Five stocks we like better than BIOLASE
- What Are Dividend Achievers? An Introduction
- This Small Cap Wealth Management Stock Could Provide Big Returns
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Airline Stocks – Top Airline Stocks to Buy Now
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.
